Table 1.
Author | Year | Country | Workplace | Vaccine | Participants, n | Vaccinated, n (%) |
---|---|---|---|---|---|---|
Ferro A et al. [7] | 2020 | Italia | Manufacturing company | Influenza | 408 | 60 (14.7%) |
Elawad KH et al. [17] | 2017 | Qatar | Primary health care corporation centers | Influenza | 4082 | 3629 (88.9%) |
Montejo L et al. [18] | 2017 | USA | Retail workers | Influenza | 246 | 91 (37.0%) |
Ofstead CL et al. [19] | 2013 | USA | Industrial factories | Influenza | 13,520 | 3144 (23.2%) |
Samad AH et al. [20] | 2006 | Malaysia | Petrochemical company | Influenza | 1022 | 504 (49.3%) |
Santoro N et al. [8] | 2004 | Argentina | Chemical company | Influenza | 6143 | 3436 (55.9%) |
Liu YH et al. [21] | 2004 | Taiwan | Electronics manufacturing company | Influenza | 2384 | 925 (38.8%) |
Morales A et al. [22] | 2004 | Colombia | Bank employees | Influenza | 759 | 424 (55.9%) |
Leighton L et al. [23] | 1996 | UK | Service company | Influenza | 2557 | 601 (23.5%) |
Nolan K et al. [24] | 2006 | USA | Multiple workplaces | Lyme disease | 190 | 30 (15.8%) |
Donoghue AN et al. [25] | 2019 | Multicentric | Welders (Multi-national company) | Pneumococcal | 767 | 241 (31.4%) |
Randi BA et al. [26] | 2019 | Brazil | Hospital | Tdap | 443 | 175 (39.5%) |
Ostovari M et al. [27] | 2017 | USA | Public university | Influenza | 8332 | 2835 (34.0%) |
Tdap | 8332 | 475 (5.7%) |